NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 212 filers reported holding NEKTAR THERAPEUTICS in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,110 | +77650.0% | 1,376 | 0.0% | 0.00% | – |
| Q3 2022 | $4 | -20.0% | 1,376 | 0.0% | 0.00% | – |
| Q2 2022 | $5 | -28.6% | 1,376 | 0.0% | 0.00% | – |
| Q1 2022 | $7 | -63.2% | 1,376 | 0.0% | 0.00% | – |
| Q4 2021 | $19 | -24.0% | 1,376 | 0.0% | 0.00% | – |
| Q3 2021 | $25 | -3.8% | 1,376 | -10.8% | 0.00% | – |
| Q2 2021 | $26 | -16.1% | 1,542 | 0.0% | 0.00% | – |
| Q1 2021 | $31 | +19.2% | 1,542 | +2.1% | 0.00% | – |
| Q4 2020 | $26 | – | 1,511 | – | 0.00% | – |
Download | ||||||